⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AIM News
AIM ImmunoTech Inc.
Form 8-K
sec.gov
AIM
AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program
globenewswire.com
AIM
AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones
globenewswire.com
AIM
International Sandberg Development to Build New U.S. Headquarters in Prince William County
businesswire.com
AIM
AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series
globenewswire.com
AIM
BULL
AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer
globenewswire.com
AIM
CIRI Announces 2026 Annual General Meeting Voting Results
globenewswire.com
AGI
TD
IMO
MFI
MX
AIM
Form 8-K
sec.gov
AIM
AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
globenewswire.com
AIM
Form 8-K
sec.gov
AIM